Ardhavabhedaka described under Shiroroga (disease of the head in Ayurveda) occurs due to vitiation of Tridosha (all of three biological humors). The signs and symptoms of migraine can be correlated with Ardhavabhedaka. Looking to the agony caused during acute episode of migraine and unavailability of specific management and only symptomatic management in conventional medicine this study was conducted. Agnikarma is indicated in severe pain and Pathyadi decoction is indicated in the management of Shiroroga. Aim and Objective: The aim of this study was to evaluate the efficacy of Agnikarma and Pathyadi decoction in the management of Ardhavabhedaka (migraine). Materials and Methods: A total of 15 patients were selected from outpatient department of Ayurveda College. Agnikarma was done on affected temporal side of face, dot type for 1 time, once in a week followed by application of honey-Ghee. Along with this, Pathyadi decoction 40 ml twice a day for 30 days was also given. Results: Statistically highly significant relief (P < 0.001) was noted in headache, photophobia and phonophobia and statistically significant (P < 0.05) relief was noted in vomiting, nausea and vertigo. Conclusion: Agnikarma along with Pathyadi decoction can be considered as an effective line of treatment to manage Ardhavabhedaka (migraine).
Introduction
Ardhavabhedaka is one of the Shiroroga (disorder of head) which can be correlated with migraine having symptoms like paroxysmal unilateral (half cranial) headache sometime associated with vertigo, nausea, photophobia and phonophobia. As per Acharya Sushruta Ardhavabhedaka occur due to vitiation of Tridosha (Vata -Pitta -Kapha). [1] While Acharya Charaka had mentioned that vitiated Vata/Vata -Kapha are involved in manifestation of Ardhavabhedaka, [2] while Acharya Vagbhatta believed that Ardhavabhedaka occurs due to vitiated Vata. [3] According to International headache society, migraine is the most common neurovascular headache and is a common disabling primary headache disorder. It is now recognized as a chronic illness, not simply as headache. Migraine headache often limited the degree to which headache sufferers could engage in regular activities. [4] In the global burden of disease survey 2010, it was ranked as the third most prevalent disorder and 7 th highest specific cause of disability worldwide. [5] The world health organization (WHO) ranks migraine among the world's most disabling medical illness. It is three times more common in women than men.
As per Ayurveda, 'pain can not occur without involvement of Vata Dosha'. [6] Agnikarma (local cauterization) having Ushna (hot), Tikshna (penetrating) property may pacify the aggravated Vata Dosha and thus, Agnikarma can be beneficial in Ardhavabhedaka. Furthermore, Agnikarma is easy and quick procedure to perform and also effective. Thus, Agnikarma has been selected as the choice of treatment procedure in this trial.
Pathyadi deccoction [7] is mentioned in Sharangdhara Samhita, especially in the management of Shiroroga. This decotion has ingredients having Ushna Virya (hot potency) and Vata Shamaka (Vata subsiding) property which can be beneficial in Ardhavabhedaka as this disease has dominancy of vitiation of Vata and Kapha Dosha, dominancy. Further it is also being widely practiced to manage Shiroroga.
Aim and objectives
The aim of this study is to evaluate the efficacy of Agnikarma and Pathyadi decoction in the management of Ardhavabhedaka (migraine).
Materials and Methods

Patients
• In the present study, 15 patients fulfilling the criteria for diagnosis of Ardhavabhedaka (migraine) were selected from the outpatient department of Shalakyatantra Govt. Akhandanand Ayurveda college, Ahmedabad, Gujarat, India.
Drug
Pathyadi decoction was procured from Government Ayurved Pharmacy, Rajpipala, Gujarat, India.
The research protocol was approved by the Institutional ethics committee (Certi. No. 28; date: 25/06/2016) and registered in clinical trial registry of India vide CTRI/2017/01/007845. Informed consent from each enrolled patient was obtained before commencement of the treatment.
Diagnostic criteria
• The diagnosis was made on following criteria of migraine.
• At least 5 episode of headache, in past history fortnightly or at 10 days interval or random occurrence (Pakshahat (madrosis)-Dashahat-Aksmatprvartate) • Headache episode lasting for 4-72 h • Headache has at least 2 or 3 of the following four characteristics. i. Unilateral location ii. Pulsating quality iii. Moderate or severe pain intensity iv. Aggravation by or leading to avoidance of routine physical activity (e.g., walking or climbing stairs). • During headache at least one of the following:
i. Nausea or vomiting ii. Photophobia and or phonophobia.
Inclusion criteria
Patients fulling the diagnostic criteria of either sex having age between 16 to 70 years and willing to participate and provide consent were included. 
Exclusion criteria
Examinations
• Vitals examination -Pulse, temperature, blood pressure, respiration and general examination of eye, ear, nose, throat, head and oral cavity was done before initiating the treatment. • Investigations were carried out before treatment like routine hematological tests complete blood count (CBC), bleeding time (BT), clotting time (CT).
Treatment trial
All the patients (n = 15) were administered treatment trial as follow.
Agnikarma. [8] E q u i p m e n t : P a n c • Post-Procedure: immediately after burn, mixture of honey (1 ml)-Ghrita (2 ml) (unequal quantity) was applied to that site • Instructions: After Agnikarma, patients were instructed to avoid washing that part for 24 hours to avoid any infection. After Agnikarma, all the patients were asked to apply mixture of honey -Ghrita 2 times a day for next 7 days for better wound healing effect.
• Pathyadi decoction [6] was given in the dose [10] of 40 ml, [ Table 1 ]. Time of intake was 2 times/day, morning and evening (empty stomach) for 30days (along with Agnikarma).
Preparation [11] for Pathyadi decoction to this patient was given 20 gms of coarse powder of Pathyadi decoction and instructed to soak that powder overnight in 320 ml of water. Next morning, patient was instructed to boil that mixture till quantity was reduced to 40ml. then it should be filtered and drink while it is luke warm.
Assessment criteria
• Symptoms of Ardhavabhedaka were given gradations as per the severity • Headache was graded according to HIT-6 [Headache impact test-6] (annexure 1) • Results were assessed before and after the treatment on the basis of change in the grade.
Assessment of overall effect of therapy
• Overall effect of therapy was assessed in terms of complete remission if 100% improvement in symptoms and no recurrences during the follow-up period was observed. When improvement in symptoms was between 75% and 100%, it was considered as marked improvement and as moderate improvement when the improvement in symptoms was between 50% and 75%. Mild improvement when the improvement in the symptoms was between 25% and 50%. Changes up to 25% were taken as no change.
Statistical analysis
Obtained data of before and after treatment was analyzed statistically with Wilcoxon signed rank test by using Sigma 
Results
• The present trial drugs provided highly significant (P < 0.001) result in headache, nausea, vomiting, vertigo and photophobia [ Table 2 ]. No any complication of the procedure or adverse drug reaction was found during this trial.
Effect of therapy on sign and symptoms
In headache, 72.22% relief was found which was statistically highly significant at the level of P < 0.001. In Hrillasa (nausea), 100% relief was found and the result was statistically significant at the level of P = 0.004. In Chhardi (vomiting), 100% relief was found, the result was statistically significant at the level of P 0.016. In Bhrama (vertigo), 100% relief was found, which was statistically significant at the level of P 0.016. In Shabda Asahishnuta (phonophobia), 100% relief was found, which was statistically highly significant at the level of P < 0.01. In Prakasha Asahishnuta (photophobia), 100% relief was found, which was statistically highly significant at the level of P < 0.01.
Overall effect of therapy
• On analyzing overall effect of therapy; maximum number of patients had marked improvement, that is, 11 (78.6%); 2 (14.3%) patient had complete remission while 1 (7.14%) patient had moderate improvement [ Table 3 ].
Discussion
In present study Shirah-Shoola (headache) was taken as chief complaint and 100% patients had headache. Along with headache there were associated complaints like nausea, vomiting, vertigo, phonophobia and photophobia.
Among these nausea and vomiting indicated vitation of Rasavaha Srotasa in manifestation of Ardhavabhedaka.
While Bhrama is one of the features of vititated Vata and Pitta Dosha. photophobia and phonophobia is not specified as symptoms in Ardhavabhedaka, but is the progressive stage of disease, loss of vision and hearing impairment (Nayana and Shravana Vinashyet) may be present as complication. Hence, photophobia and phonophobia may be considered as systemic manifestations of the disease.
In the present study, in Headache, 72.22% (P < 0.001) relief and 100% relief in nausea, vomiting, vertigo, phonophobia and photophobia was found. Three patients (21.43%) had the recurrence of headache at the end of the course but severity, duration and frequency were decreased significantly. All these patients had to take analgesic medicine before treatment but after treatment none of the patients had to take analgesics for the same.
Probable mode of action of Agni Karma
Heat is often used to relieve pain in many diseases, however, the exact mode of its action and mechanism is not clearly understood.
According to Ayurveda, Agni has Ushna Guna. This Ushna Guna gets transferred to Twaka (skin) by Agnikarama. This
Guna normalises Vata and Kapha. This might have helped to reduce Shira -Shoola in Ardhavabhedaka.
The local thermos therapy may increase tissue metabolism and toxins. Heat may stimulate lateral spinothalamic tract which leads stimulation of descending pain inhibitory fibers which release endogenous opioid peptide which binds with opiod receptors at substantia gelatinosa rolandi which inhibit release of P-substance (Presynaptic inhibition) and blockage of transmission of pain sensation occur. [12] Heat has also been claimed to act as a counter irritant. It has been suggested that such responses might be explained on the basis of the pain gate control theory. In this theory, it is believed that nociceptor fibers residing in the superficial skin get stimulated by heat. These fast-acting fibers after activating, close the gate for slow-acting fibers for chronic pain. [13] 
Probable mode of action of Pathyadi decoction
This formulation is a multidrug combination and is indicated specially in Shiroroga in Shrangdhara Samhita. [ It is reported that most of the drugs of Pathyadi decoction also possess analgesic, anti-inflammatory, a nervine tonic property which might have helped to reduce pain.
Conclusion
Agnikarma and Pathyadi decoction provided significant relief in the symptoms of Ardhavabhedaka (migraine). Agnikarma has provided significant relief in pain, whereas, Pathyadi decoction may have acted on systemic symptoms such as nausea, vomiting and vertigo.
Thus Agnikarma and Pathyadi decoction therapy are effective in the management of Ardhavebhedaka (migraine). Further research work on Agnikarma as pain management should be done on large sample size.
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